Concepedia

Vivek Abraham

VA

4

Publications

324

Citations

4

H-Index

1999

Active since

Affiliations

May Institute(Current)

Vivek Abraham is an author at May Institute specializing in drug discovery, tumor biology, and tumor immunity.

ORCID

Top concepts

Publications per year

1999–2022

4

Publications

4

The Bcl-2/Bcl-XL/Bcl-w Inhibitor, Navitoclax, Enhances the Activity of Chemotherapeutic Agents <i>In Vitro</i> and <i>In Vivo</i>

Jun Chen, Sha Jin, Vivek Abraham et al. · Molecular Cancer Therapeutics · 2011 · 147 citations

, , +20

Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier

Kaijun Di, G. Kenneth Lloyd, Vivek Abraham et al. · Neuro-Oncology · 2015 · 137 citations · Full text

Machine-learning Models Predict 30-Day Mortality, Cardiovascular Complications, and Respiratory Complications After Aseptic Revision Total Joint Arthroplasty

Vivek Abraham, Greg Booth, Phillip Geiger et al. · Clinical Orthopaedics and Related Research · 2022 · 21 citations · Full text

Microinjection of cyclic ADP-ribose triggers a regenerative wave of Ca<sup>2+</sup> release and exocytosis of cortical alveoli in medaka eggs

Richard A. Fluck, Vivek Abraham, Andrew L. Miller · Zygote · 1999 · 19 citations

Rows per page

1–4 of 4